Search

Minh Duc Gia Pham

Examiner (ID: 9692, Phone: (571)270-1789 , Office: P/3762 )

Most Active Art Unit
3762
Art Unit(s)
3792, 3762
Total Applications
288
Issued Applications
178
Pending Applications
1
Abandoned Applications
111

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17443640 [patent_doc_number] => 20220064145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => SYNTHESIS OF POZIOTINIB DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/458031 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458031 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/458031
SYNTHESIS OF POZIOTINIB DERIVATIVE Aug 25, 2021 Abandoned
Array ( [id] => 18724126 [patent_doc_number] => 20230338246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => ANTIPERSPIRANT STICK COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/004997 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7053 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004997 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004997
ANTIPERSPIRANT STICK COMPOSITIONS Jul 8, 2021 Pending
Array ( [id] => 17314373 [patent_doc_number] => 20210403421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => BIODEGRADABLE SURFACTANTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 17/350875 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350875 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/350875
BIODEGRADABLE SURFACTANTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS Jun 16, 2021 Pending
Array ( [id] => 20593555 [patent_doc_number] => 12577257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Heterocyclic compounds [patent_app_type] => utility [patent_app_number] => 17/325934 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21402 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325934 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/325934
Heterocyclic compounds May 19, 2021 Issued
Array ( [id] => 18468740 [patent_doc_number] => 20230203022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/922124 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922124 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/922124
HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF Apr 28, 2021 Pending
Array ( [id] => 18724220 [patent_doc_number] => 20230338345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => DRUG COMBINATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/918604 [patent_app_country] => US [patent_app_date] => 2021-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21985 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918604 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918604
DRUG COMBINATION AND USE THEREOF Apr 21, 2021 Pending
Array ( [id] => 18657630 [patent_doc_number] => 20230303557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => CRYSTALLINE FORM OF TLR8 AGONIST [patent_app_type] => utility [patent_app_number] => 17/931456 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931456 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/931456
Crystalline form of TLR8 agonist Mar 17, 2021 Issued
Array ( [id] => 18282782 [patent_doc_number] => 20230098254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA [patent_app_type] => utility [patent_app_number] => 17/909422 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16644 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909422 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909422
SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA Mar 7, 2021 Pending
Array ( [id] => 16898072 [patent_doc_number] => 20210176988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => LIQUID FORMULATION OF BIPHENYL-CONTAINING COMPOUND AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/187877 [patent_app_country] => US [patent_app_date] => 2021-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187877 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/187877
Liquid formulation of biphenyl-containing compound and application thereof Feb 27, 2021 Issued
Array ( [id] => 18466856 [patent_doc_number] => 20230201136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHODS AND MATERIALS FOR DIAGNOSIS AND TREATMENT OF NEURONAL DISORDER [patent_app_type] => utility [patent_app_number] => 17/802908 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802908 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/802908
Methods and materials for diagnosis and treatment of neuronal disorder Feb 25, 2021 Issued
Array ( [id] => 18307098 [patent_doc_number] => 20230110998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => Compositions and Methods for Treatment of Cytokine Storm and Cytokine Release Syndrome [patent_app_type] => utility [patent_app_number] => 17/801434 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801434
Compositions and Methods for Treatment of Cytokine Storm and Cytokine Release Syndrome Feb 23, 2021 Pending
Array ( [id] => 18752328 [patent_doc_number] => 20230355553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 17/799149 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799149 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/799149
COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS Feb 10, 2021 Pending
Array ( [id] => 17005345 [patent_doc_number] => 20210236506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => NOVEL USES [patent_app_type] => utility [patent_app_number] => 17/173069 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173069 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173069
NOVEL USES Feb 9, 2021 Abandoned
Array ( [id] => 18268288 [patent_doc_number] => 20230089530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS [patent_app_type] => utility [patent_app_number] => 17/797772 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797772 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/797772
QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS Feb 4, 2021 Pending
Array ( [id] => 20756978 [patent_doc_number] => 12649737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-09 [patent_title] => Compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/795929 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26758 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795929 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/795929
Compounds and uses thereof Jan 28, 2021 Issued
Array ( [id] => 18228283 [patent_doc_number] => 20230067277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS [patent_app_type] => utility [patent_app_number] => 17/793669 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793669 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/793669
ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS Jan 19, 2021 Abandoned
Array ( [id] => 19210699 [patent_doc_number] => 11999747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Furoquinolinediones as inhibitors of TDP2 [patent_app_type] => utility [patent_app_number] => 17/146327 [patent_app_country] => US [patent_app_date] => 2021-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11634 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/146327
Furoquinolinediones as inhibitors of TDP2 Jan 10, 2021 Issued
Array ( [id] => 17299442 [patent_doc_number] => 20210395281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => MACROCYCLIC CHELATES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/272129 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/272129
MACROCYCLIC CHELATES AND USES THEREOF Jan 7, 2021 Pending
Array ( [id] => 18451330 [patent_doc_number] => 20230192607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/789023 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -131 [patent_words_short_claim] => 574 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789023 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789023
TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF Dec 22, 2020 Pending
Array ( [id] => 18160104 [patent_doc_number] => 20230026696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => TRPV4 RECEPTOR LIGANDS [patent_app_type] => utility [patent_app_number] => 17/778584 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28860 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778584 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778584
TRPV4 RECEPTOR LIGANDS Nov 19, 2020 Pending
Menu